Amphotericin B and Itraconazole: Clinical Management, Indications, Side Effects

Amphotericin B

Indications:

Amphotericin B is a broad-spectrum antifungal used for the treatment of severe, life-threatening systemic fungal infections, such as:

• Cryptococcal meningitis (especially in immunocompromised patients, like those with HIV/AIDS)
• Invasive aspergillosis
• Candidiasis (especially invasive candidiasis)
• Mucormycosis
• Histoplasmosis
• Coccidioidomycosis

It is typically reserved for serious fungal infections because of its significant toxicity profile.

Drug Management & Administration:

• Conventional Amphotericin B (Deoxycholate):
  • Dose: 0.5–1.5 mg/kg/day IV over 2–6 hours.
  • Requires close monitoring due to high risk of nephrotoxicity.
• Lipid-based formulations (Liposomal Amphotericin B, Amphotericin B lipid complex):
  • Dose: 3–5 mg/kg/day IV.
  • Liposomal formulations are preferred in patients at high risk for renal toxicity as they are less nephrotoxic.
• Pre-medication: Administer antipyretics (e.g., acetaminophen), antihistamines, and sometimes corticosteroids to prevent infusion-related reactions such as fever, chills, and rigors.

Side Effects:

1. Nephrotoxicity (Acute Kidney Injury - AKI):
   • Most common and serious side effect.
   • Mechanism: Direct tubular damage and afferent arteriole vasoconstriction leading to reduced renal blood flow.
   • Management: Adequate hydration with normal saline before and after administration, regular monitoring of serum creatinine, and switching to liposomal formulations if necessary.
2. Type 1 Renal Tubular Acidosis (RTA):
   • Results in hypokalemia and hypomagnesemia.
   • Management: Monitor and replace potassium and magnesium as needed.
3. Electrolyte Imbalance:
   • Hypokalemia and hypomagnesemia.
   • Regular monitoring and supplementation are required.
4. Infusion-related reactions:
   • Fever, chills, rigors.
   • Management: Pre-medication with acetaminophen and antihistamines; use of liposomal formulations reduces these reactions.
5. Anemia:
   • Amphotericin B suppresses erythropoiesis, leading to normocytic, normochromic anemia with prolonged use.
6. Hepatotoxicity (rare).

---

Itraconazole

Indications:

Itraconazole is an oral triazole antifungal that is used for:

• Blastomycosis
• Histoplasmosis
• Sporotrichosis
• Aspergillosis (especially in chronic or allergic forms)
• Onychomycosis (fungal nail infections)

Itraconazole is preferred for less severe or chronic infections compared to Amphotericin B.

Drug Management & Administration:

• Oral Capsules:
  • Dose: 200 mg once or twice daily depending on the infection.
  • For onychomycosis, 200 mg daily for 12 weeks is commonly used.
• Oral Solution:
  • Better absorption when taken on an empty stomach.
  • Dose: 200 mg twice daily for systemic infections like aspergillosis.
• Food Interactions: Capsules should be taken with food for better absorption, whereas the oral solution should be taken on an empty stomach.

Side Effects:

1. Hepatotoxicity:
   • Elevations in liver enzymes are common.
   • Monitoring: Routine liver function tests (LFTs) are recommended, especially with long-term therapy.
2. Cardiotoxicity:
   • Can lead to heart failure or worsening of existing heart failure.
   • Contraindicated in patients with congestive heart failure.
3. Drug interactions:
   • Potent CYP3A4 inhibitor, leading to significant interactions with drugs metabolized by this enzyme (e.g., statins, anticoagulants).
   • Careful review of all patient medications is essential to avoid interactions.
4. GI side effects: Nausea, vomiting, diarrhea.
5. Headache and dizziness: Common, but typically mild.

---

Management and Monitoring

For both drugs, appropriate management involves:

• Amphotericin B: Close monitoring of renal function, electrolytes (especially potassium and magnesium), and for any infusion-related reactions. Use lipid-based formulations when possible to reduce nephrotoxicity.
• Itraconazole: Monitor liver function regularly, check for signs of heart failure, and review potential drug interactions due to CYP3A4 inhibition.

---

Prescription Examples:

Amphotericin B (Liposomal formulation)

• Dose: 3 mg/kg/day IV.
• Route: IV infusion over 2–6 hours.
• Pre-medications: Acetaminophen 500 mg PO and diphenhydramine 50 mg IV 30 minutes before infusion.
• Monitoring: Serum creatinine, electrolytes (potassium and magnesium), daily urine output, and regular complete blood counts for anemia.
• Hydration: 500–1000 mL of normal saline before infusion to prevent nephrotoxicity.

Itraconazole

• Dose: 200 mg PO twice daily (for systemic fungal infections).
• Route: Oral.
• Administration: Take capsules with food, or the oral solution on an empty stomach.
• Monitoring: Liver function tests every 1–2 weeks initially, then monthly if long-term therapy is planned. Monitor for signs of heart failure, especially in high-risk patients.

---

Summary of Management Approach:

Amphotericin B:

• Indications: Severe systemic fungal infections (cryptococcal meningitis, invasive aspergillosis).
• Administration: IV, 0.5–1.5 mg/kg/day (conventional) or 3–5 mg/kg/day (liposomal).
• Side Effects: AKI, electrolyte imbalances, infusion reactions, anemia.
• Monitoring: Renal function, electrolytes, pre-medication to prevent infusion reactions.

Itraconazole:

• Indications: Less severe fungal infections (blastomycosis, histoplasmosis, onychomycosis).
• Administration: Oral, 200 mg once or twice daily.
• Side Effects: Hepatotoxicity, cardiotoxicity, drug interactions.
• Monitoring: Liver function, heart function, and potential drug interactions.